Announcements Trials
Browse Landscape

Phase

Phase 2 105Phase 1 41Phase 1/2 38Phase 3 21Phase 2/3 7Phase EARLY_PHASE1 6Phase NA 4Phase 4 4

Status

Recruiting 4Completed 4Unknown 2Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 2CNS 1

Conditions

Melanoma 2Solid Carcinoma 1Skin Neoplasms 1Glioma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Blood Specimen Collection 104Standard of Care 79Exercise 67Radiotherapy 53Radiosurgery 48Specimen Handling 45Magnetic Resonance Spectroscopy 45Surveys and Questionnaires 44Interviews as Topic 44Practice Guidelines as Topic 43Educational Status 43Methods 41Drug Therapy 35Early Intervention, Educational 30Surgical Procedures, Operative 29Palliative Care 25Control Groups 25Biopsy 24Patient Navigation 18venetoclax 17Cisplatin 17Therapeutics 16Resistance Training 16Proton Therapy 15Magnetic Resonance Imaging 15Behavior Therapy 15Neoadjuvant Therapy 13Cognitive Behavioral Therapy 13Acupuncture Therapy 13Nutritional Status 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Nivolumab × Clear all
NCT07422779 2026-02-20

MAK

Institute of Oncology Ljubljana

Phase NA Recruiting
100 enrolled
Dermatologic

Melanoma, Skin Neoplasms

NCT05533983 2025-12-03

NIVO-FMT

Asan Medical Center

Phase NA Recruiting
50 enrolled

Solid Carcinoma

NCT06519682 2025-08-29

A Pilot Study Investigating Upfront Adaptive Immunotherapy Approach in Children, Adolescent and Young Adult (CAYA) Patients With Replication-Repair Deficient (RRD) High-Grade Gliomas (HGG)

The Hospital for Sick Children

Phase NA Recruiting
20 enrolled
CNS

Glioma

NCT05652673 2025-02-28

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

Erasmus Medical Center

Phase NA Recruiting
80 enrolled
Dermatologic

Melanoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡